Dr. Martin Alexander Gershon, MD, JD, MPH is a distinguished healthcare and life sciences innovation strategist, futurist, and advisor. He currently serves as the Managing Partner and Chief Investment Officer (CIO) of Endeavor Venture Funds and Endeavor Venture Studio. With a robust background in both medicine and law, Dr. Gershon has carved out a unique niche in the venture capital and healthcare sectors, making significant contributions to the commercialization of groundbreaking technologies.

Dr. Gershon’s career spans over two decades, during which he has founded six startups and led Endeavor Venture Funds through more than 100 investments and 24 successful exits. His expertise and visionary approach have earned him recognition as a “Top Voice” in Venture Capital and Entrepreneurship by LinkedIn and a Top 100 Healthcare Industry Leader by Standard and Poor’s. His insights and strategic acumen have been featured on CNBC and in Fast Company, reinforcing his stature as a leading figure in healthcare innovation.

At Endeavor, Dr. Gershon leverages an extensive ecosystem of partnerships to provide bespoke growth strategies, FDA regulatory services, and clinical trial design guidance to emerging healthcare companies. This collaborative network includes industry giants such as Microsoft, Merck, Sanofi, Mount Sinai, and Johns Hopkins, among others. These alliances enable Endeavor to deliver prescient investments and strategic advice to Fortune 500 companies and unicorn startups alike.

Dr. Gershon’s advisory roles extend to prestigious organizations including the White House Moonshot CancerX Accelerator Program, McKinsey, Goldman Sachs, Bain Capital, and the Bill and Melinda Gates Foundation. His contributions in these capacities have helped shape growth strategies and commercialization efforts for numerous Fortune 500 companies and global leaders in healthcare, tech, and finance.

In addition to his investment and advisory work, Dr. Gershon is a prominent thought leader and educator. He hosts the popular Endeavor BetterHealth Webinar Series and serves as Editor-in-Chief for the Partnering for BetterHealth Newsletter. He has also lectured on healthcare economics, AI, and entrepreneurship at institutions such as Harvard, Johns Hopkins, Columbia, and McGill.

Dr. Gershon’s educational background is as impressive as his professional achievements. He is a Harvard, McGill, and Columbia-trained neuroscientist, oncologist, and immunologist, as well as a former FDA attorney. He has also been honored as a Google Scholar in Entrepreneurship and a Memorial Sloan-Kettering Cancer Center Mayday Fellow.

Through Endeavor Venture Studio, Dr. Gershon continues to drive innovation by incubating and accelerating startups with disruptive potential. His leadership and vision have positioned Endeavor as a beacon for emerging healthcare and life sciences companies seeking to scale and commercialize their innovations.

Join us at the Keiretsu Forum 2024 Investor Capital Expo to hear Dr. Gershon share his invaluable insights on the future of healthcare and technology.

Dr. Martin Alexander Gershon, MD, JD, MPH

Managing Partner and CIO, Endeavor Venture Funds and Venture Studio

Email: endeavor@gershoncapital.com

LinkedIn: linkedin.com/in/martingershon